Reference number : 236-2017-2018-Q1-00676, amendment number : , agreement type : G, recipient legal name : Leclerc, Denis, recipient country : CA, recipient province : QC, recipient city : Québec, recipient postal code : G1K 7P4, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 250000.0, agreement start date : 2017-06-01, agreement end date : 2018-11-30, description english : Adjuvantization of SIV antigens using a novel toll like receptor 7 (TLR7) agonist: A proof of concept in non human primate., description french : Adjuvantization of SIV antigens using a novel toll like receptor 7 (TLR7) agonist: A proof of concept in non human primate., expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2017-18 to 2018-19), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2017-18 à 2018-19), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada